Resource

Comparing Medications Added to a Serotonin Reuptake Inhibitor to Treat Patients with PTSD

View the Final Research Report

The objective of this study was to compare the effect of augmenting medications in patients with posttraumatic stress disorder (PTSD) who take a serotonin reuptake inhibitor (SRI) on their mental and physical health.

Project page: Comparing Medications Added to a Serotonin Reuptake Inhibitor to Treat Patients with PTSD
Principal Investigator: Beth Cohen, MD, MAS
Organization: University of California San Francisco
Original project title: Improving Care for Veterans with PTSD: Comparative Effectiveness of Medications to Augment First-line Pharmacotherapy
HSRProj ID: 20163069

To cite this document, please use: Cohen B, Maguen S, Seal K, Neylan T. (2021). Comparing Medications Added to a Serotonin Reuptake Inhibitor to Treat Patients with PTSD. Patient-Centered Outcomes Research Institute (PCORI). https://doi.org/10.25302/05.2021.CER.150731834

Tags

Resource Type

What's Happening at PCORI?

The Patient-Centered Outcomes Research Institute sends weekly emails about opportunities to apply for funding, newly funded research studies and engagement projects, results of our funded research, webinars, and other new information posted on our site.

Subscribe to PCORI Emails
Hand pointing to email icon